Cargando…

Use of proton pump inhibitors in general practice

AIM: To evaluate the characteristics of the prescription of the proton pump inhibitor drugs (PPI) and the adherence to the indications of the guidelines regulating the reimbursement limitations set forth by the Italian Drug Agency. METHODS: Thirty general practitioners (GP) participated in the study...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tosetti, Cesare, Nanni, Ilaria
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Baishideng Publishing Group Inc 2017
Materias:	Retrospective Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5547376/ https://www.ncbi.nlm.nih.gov/pubmed/28828196 http://dx.doi.org/10.4292/wjgpt.v8.i3.180

Ejemplares similares

Comparative study: Vonoprazan and proton pump inhibitors in Helicobacter pylori eradication therapy
por: Sakurai, Kouichi, et al.
Publicado: (2017)

Washed microbiota transplantation reduces proton pump inhibitor dependency in nonerosive reflux disease
por: Zheng, Ya-Mei, et al.
Publicado: (2021)

Effects of postoperative use of proton pump inhibitors on gastrointestinal bleeding after endoscopic variceal treatment during hospitalization
por: Zhang, Yi-Yan, et al.
Publicado: (2023)

Proton pump inhibitor use increases mortality and hepatic decompensation in liver cirrhosis
por: De Roza, Marianne Anastasia, et al.
Publicado: (2019)

Influence of proton pump inhibitors in the development of spontaneous bacterial peritonitis
por: Miozzo, Suelen A S, et al.
Publicado: (2017)

Two-stage surgical treatment for septic non-union of the forearm
por: Perna, Fabrizio, et al.
Publicado: (2017)

Continuous intravenous infusion of recombinant human endostatin using infusion pump plus chemotherapy in non-small cell lung cancer
por: Qin, Zhi-Quan, et al.
Publicado: (2022)

Proton pump inhibitors increase risk of COVID-19
Publicado: (2020)

Proton pump inhibitors increase the severity of hepatic encephalopathy in cirrhotic patients
por: Fasullo, Matthew, et al.
Publicado: (2019)

Clostridium difficile Infection and Proton Pump Inhibitor Use in Hospitalized Pediatric Cystic Fibrosis Patients
por: Pohl, John F., et al.
Publicado: (2011)

High-flow nasal oxygen availability for sedation decreases the use of general anesthesia during endoscopic retrograde cholangiopancreatography and endoscopic ultrasound
por: Schumann, Roman, et al.
Publicado: (2016)

Risk factors for major gastrointestinal bleeding in the general population in Finland
por: Vora, Pareen, et al.
Publicado: (2022)

Proton Pumps: Molecular Mechanisms, Inhibitors and Activators of Proton Pumping
por: Siletsky, Sergey A.
Publicado: (2023)

Use and overuse of proton pump inhibitors
por: Staiano, Annamaria, et al.
Publicado: (2015)

Proton pump inhibitor use: systematic review of global trends and practices
por: Shanika, Lelwala Guruge Thushani, et al.
Publicado: (2023)

Proton pump inhibitor induced collagen expression in colonocytes is associated with collagenous colitis
por: Mori, Shiori, et al.
Publicado: (2017)

The Therapeutic Effectiveness of the Coadministration of Weekly Risedronate and Proton Pump Inhibitor in Osteoporosis Treatment
por: Tanaka, Mizue, et al.
Publicado: (2014)

Remdesivir, dexamethasone and angiotensin-converting enzyme inhibitors use and mortality outcomes in COVID-19 patients with concomitant troponin elevation
por: Umeh, Chukwuemeka A, et al.
Publicado: (2023)

Validity of electrocardiographic criteria for increased left ventricular mass in young patients in the general population
por: Sklyar, Eduard, et al.
Publicado: (2017)

Identification of independent risk factors for intraoperative gastroesophageal reflux in adult patients undergoing general anesthesia
por: Zhao, Xiao, et al.
Publicado: (2021)

Immune checkpoint inhibitor-mediated colitis is associated with cancer overall survival
por: Weingarden, Alexa R, et al.
Publicado: (2022)

Proton pump inhibitors versus histamine-2 receptor blockers for stress ulcer prophylaxis in patients with sepsis: a retrospective cohort study
por: Huang, Minqiang, et al.
Publicado: (2021)

Effects of proprotein convertase subtilisin/kexin type-9 inhibitors on fatty liver
por: Shafiq, Muhammad, et al.
Publicado: (2020)

Effects of angiotensin receptor blockers and angiotensin-converting enzyme inhibitors on COVID-19
por: Li, Xiao-Long, et al.
Publicado: (2021)

Proton Pump Inhibitor Usage and the Risk of Myocardial Infarction in the General Population
por: Shah, Nigam H., et al.
Publicado: (2015)

Generalized structural equation modeling: Symptom heterogeneity in attention-deficit/hyperactivity disorder leading to poor treatment efficacy
por: Tzang, Ruu-Fen, et al.
Publicado: (2022)

Proton Pump Inhibitors and Gastritis
por: Suzuki, Masayuki, et al.
Publicado: (2008)

Proton pump inhibitors and gastroenteritis
por: Hassing, Robert-Jan, et al.
Publicado: (2016)

Deprescribing proton pump inhibitors
por: Teh, Kim Jun Kevin, et al.
Publicado: (2023)

Clinical Intervention Increases Rational Use of Proton Pump Inhibitors in the General Surgery Department
por: Chen, Qiying, et al.
Publicado: (2022)

Machine learning models for predicting non-alcoholic fatty liver disease in the general United States population: NHANES database
por: Atsawarungruangkit, Amporn, et al.
Publicado: (2021)

Influences of dexmedetomidine on stress responses and postoperative cognitive and coagulation functions in patients undergoing radical gastrectomy under general anesthesia
por: Ma, Xiang-Fei, et al.
Publicado: (2023)

When is proton pump inhibitor use appropriate?
por: Yadlapati, Rena, et al.
Publicado: (2017)

Is hypomagnesemia associated with using proton pump inhibitors?
por: Yi, Joo-Hark, et al.
Publicado: (2016)

Total joint replacement in inhibitor-positive haemophilia: Long-term outcome analysis in fifteen patients
por: Danielson, Heidi, et al.
Publicado: (2017)

Clinical characteristics of gastrointestinal immune-related adverse events of immune checkpoint inhibitors and their association with survival
por: Yamada, Kentaro, et al.
Publicado: (2021)

Efficacy of omarigliptin, once-weekly dipeptidyl peptidase-4 inhibitor, in patients with type 2 diabetes
por: Kawasaki, Eiji, et al.
Publicado: (2021)

Practical fecal calprotectin cut-off value for Japanese patients with ulcerative colitis
por: Urushikubo, Jun, et al.
Publicado: (2018)

Association between a low dose of proton pump inhibitors and kidney function decline in elderly hypertensive patients: a retrospective observational study
por: Wakabayashi, Tomohito, et al.
Publicado: (2021)

Treatment with neurohormonal inhibitors and prognostic outcome in pulmonary arterial hypertension with risk factors for left heart disease
por: Scagliola, Riccardo, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_7ilhfre4vc316qm4do7cmm53vo